摘要
目的 :观察盐酸西布曲明在不同体重病人中的减重作用。方法 :40名肥胖患者 ,根据体重指数(BMI)分组 :肥胖早期组 (n =1 0 )、Ⅰ度肥胖组 (n =1 1 )、Ⅱ度肥胖组(n =1 9) ,40名患者都给予饮食、体育活动和生活方式的改变标准化 ,在此基础上给予盐酸西布曲明 1 0mg·d-1,治疗期 1 2wk。结果 :3组病人体重均有不同程度的下降 ,服药 2wk后Ⅰ度肥胖组有效 5例 (4 5 .5 % ) ,Ⅱ度肥胖组有效 1 8例(94.7% ) (P <0 .0 1 ) ;服药 4wk ,Ⅰ度肥胖组有效 9例(81 .8% ) ,显效 1例 (9.1 % ) ,Ⅱ度肥胖组有效 3例(5 .8% ) ,显效 1 6例 (84.2 % ) (P <0 .0 1 ) ;服药1 2wk,肥胖早期组始出现 5例有效 (5 5 .6% ) ,Ⅰ度肥胖组有效 4例 (3 6.4% ) ,显效 7例 (63 .6% ) ,Ⅱ度肥胖组显效 1 9例 (1 0 0 % ) (P <0 .0 1 )。结论 :盐酸西布曲明是一安全有效的减肥药 ,并随体重的不同疗效不一 ,疗效与基础体重成正比。
AIM: To observe the effect of sibutramine in the treatment of obesity with different body weight. METHODS: Forty overweight subjects were divided into three groups according to their BMI: Group 1 (n=10), the early stage of obesity; Group 2 (n=11), obesity in degree Ⅰ; and Group 3 (n=19), obesity in degree Ⅱ. The patients conformed to the same standards of diet, sports and life style, and then took sibutramine 10 mg a day for 12 weeks. RESULTS: After taking the medicine for two weeks, the efficacy rate was 45.5 % (5) in Group 2 and 94.7 % (18) in Group 3 (P< 0.01 ); four weeks later, 81.8 % (9) in Group 2 and 5.8 % (3) in Group 3; the obvious effect rate was 9.1 % (1) in Group 2 and 84.2 % (16) in Group 3 (P< 0.01 ). After 12 weeks, the efficacy rate was 55.6 % (5) in Group 1, 36.4 % (4) in Group 2; the obvious effect rate was 63.6 % (7) in Group 2 and 100% (19) in Group 3 (P< 0.01 ). CONCLUSION: Sibutramine is safe and efficient in the treatment of obesity with different body weight. The effect increases with body weight increasing.
出处
《中国临床药理学与治疗学》
CAS
CSCD
2002年第4期327-330,共4页
Chinese Journal of Clinical Pharmacology and Therapeutics
